This paper reports the first Raman spectroscopic study of the potassium complex of the cation-specific antibiotic valinomyoin.
Introduction
The macrocyclic depsipeptide valinomycin (C54Ns018H90) is a membrane-active antibiotic with remarkably selective ion-binding properties. Its ability to facilitate potassium ion transport across mitochondrial membranes (Pressman, 1966) and egg lecithin bilayers (Shemyakin et al., 1969) suggests that a study of its complexation mechanisms may help elucidate selective ionic transport in other systems.
The valinomycin molecule consists of the sequence (L-valine, n-a-hydroxyisovaleric acid, D-valine, L-lactic acid) repeated three times (Shemyakin et al., 1963) . The structure of uncomplexed valinomycin crystals (monoclinic, space group P21) grown from warm n-octane has been determined by X-ray diffraction (Duax et al., 1972) . Unique to this conformation is the presence of intramolecularly hydrogen-bonded ester C=O groups (Fig. 1) . Although recent Raman spectroscopic data indicate that this structure is maintained in valinomycin recrystallized from several other solvents (Ccl,, CHCl,, CH,(CH,) ,Cl, CH,CN), a different solid-state conformation is found to exist in valinomycin freshly recrystallized from p-dioxane or o-dichlorobenzene (Rothschild et al., 1973 ; Asher, Rothschild, Anastassakis & Stanley, manuscript in preparation). (o) Structure of the valinomycin-K+ complex; from Pinkerton et al. (1909) , in which hydrocarbon sidegroups have been omitted. All six amide C =0 groups are H-bonded, and all six ester C = 0 groups co-ordinate the enclosed cation.
A variety of different valinomycin conformations exists in solution ; their structure and relative concentrations at equilibrium depend on the polarity and hydrogenbonding ability of the solvent. Nuclear magnetic resonance (Haynes et al., 1969; Shemyakin et al., 1969; Patel, 1973; Pate1 & Tonelli, 1973; Grell & Funck, 1973) , infrared absorption spectroscopy (Shemyakin et al., 1969; Grell & Funck, 1973) and more recently, laser Raman spectroscopy (Rothschild, Asher, Anastassakis t Stanley, manuscript in preparation) have been used to investigate the details of these conformations. In the last case this mixture of conformations is responsible for the appearance of broad bands in the amide (=1650 cm-l) and ester (=I750 cm-l) C=O stretch region.
The structure of the valinomycin-potassium ion complex was determined by Pinkerton et al. (1969) using X-ray crystallographic methods. The crystals were grown from a 1: 1 mixture of chloroform and m-xylene which was shaken with an aqueous solution of potassium aurichloride (KAuCl,). Such crystals are yellow, triclinic (space group PI) with one molecule of complex per unit cell. Complex formation depended critically on the count&on used. The potassium ion was found to be held in the internal cavity of the valinomycin molecule by co-ordination to all six ester C=O groups ( Fig. l(c) ); the K+---0 distance was found to be ~2.7 8. The valinomycin backbone forms three complete sine waves as it circles around the enclosed ion; this framework is held comparatively rigid by intramolecular H-bonds formed by all six amide C=O groups (H. . . 0 distances -1.9 A). The X-ray structure of the crystalline complex suggests that valinomycin carries potassium ions across the hydrophobic region of membranes by surrounding them in a "cage" whose outer surface (containing 12 aliphatic residues) is considerably less hydrophilic than the bare ion.
This conformation of the complex has been inferred to exist in chloroform and methanol solutions by nuclear magnetic resonance (Haynes et al., 1969 ; Shemyakin et al., 1969; Ohnishi & Urry, 1970; Patel, 1973; Pate1 & Tonelli, 1973) and infrared absorption (Shemyakin et al., 1969; Grell & Funck, 1973) techniques. For example. the infrared spectrum of valinomycin in chloroform displays amide and ester C=O stretch frequencies at 1661 cm-l and 1755 cm-l, respectively; these shift to 1657 cm-' and 1739 cm-l, on adding n-CIIH,,OSO,K (Shemyakin et al., 1969) . This downward shift and the concomitant narrowing of the ester C=O peak is taken as evidence for the uniform bonding of all six ester C=O groups to an enclosed potassium ion.
This paper reports the first Raman spectroscopic study of the valinomycinpotassium complex. Unlike the references previously cited, it includes observations of the complex in the solid state and in non-polar (Ccl,) solution. The former provides a more direct comparison with the X-ray crystallographic structure of Pinkerton et ab. (1969) ; the latter allows one to observe the effects of solvent polarity on the conformation of the complex.
Materials and Methods
Uncomplexed valinomycin was obtained commercially from Calbiochem (San Diego, Calif.) and used without further purification. Valinomycin-potassium complex was prepared by adding excesses of uncomplexed valinomycin and KSCN (or KCl) to ethanol and extracting the supernatant. Additional powdered valinomycin-KSCN complex was obtained from Professor V. T. Ivanov and his colleagues at the Shemyakin Institute for the Chemistry of Natural Products, Moscow, prepared as in Ivanov et aE. (1973) . No spectral differences were observed between samples prepared by these two methods.
Raman spectra were taken of the powdered complex and its solutions in CC14, CHCl,, and CaHSOH using a SPEX Ramalog 4 system in conjunction with a 4 W argon ion laser (Spectra-Physics Model 124). This system will be described in detail elsewhere (Asher, Rothschild, Am&ass&is & Stanley, manuscript in preparation) . All samples were held in l-mm inner diameter glass capillary tubes mounted perpendicular to the scattering plane. The effects of sample fluorescence were minimized by using the violet 4579 L% argon line and moderately slow scanning speeds (3 to 12 cm-l/n&). Spectral resolutions of 3 to 5 cm-l were sufficient for our purposes. Optical rotatory dispersion spectra of the valinomycin-KSCN complex in ethanol solution were taken with a Carey model 60 spectropolarimeter.
Results
Our results are displayed in Figures 2 and 4 and Tables 1 and 2 (the mode assignment,s are based on Asher et al., manuscript in preparation). In section (a) to (c) below we mill confine our attention to the 1600 to 1800 cm-l region, although complex forma-tion-induced changes are observed throughout the valinomycin spectrum (section (d)). The stretch vibrations of the amide ( ~1650 cm-l) and ester (~1750 cm-l) C=O groups have been shown to be particularly sensitive to valinomycin conformation in previous Raman spectroscopic studies (Rothschild et al., 1973) .
The Raman spectrum of uncomplexed valinomycin powder recrystallized from n-octane ( Fig. 2(a) ), CCI, or CHCl, contains four distinct peaks in the 1609 to 1809 cm-l region, indicating the presence of both "free" and intramolecularly hydrogenbonded amide C=O groups (1675 cm-' and 1649 cm-l, respectively) and both . "free" and intramolecularly H-bonded ester C=O groups (1767 cm-l and 1742 -1, respectively). This interpretation is consistent with the X-ray structure izcribed by Duax et al. (1972) (Fig. l(b) ). We have recently shown (Rothschild et al., 1973 ; Asher et al., manuscript in preparation) that Raman spectra of uncomplexed valinomycin freshly recrystallized from o-dichlorobenzene or p-dioxane contain only the 1767 cm-l eater C=O frequency, which implies a structure having no H-bonded ester C=O groups. This second conformation seems to resemble the predominant form of valinomycin in polar solvents as proposed by Ivanov et al. (1969) and Pate1 & Tonelli (1973) . This should make an X-ray determination of its structure more biologically relevant than that of valinomycin crystallized from n-octane.
(a) Solid state
The Raman spectrum (1600 to 1800 cm-l) of powdered valinomycin-KSCN complex ( Fig. 2(b) ) is strikingly different from that of uncomplexed valinomycin ( Fig. 2(a) ). The amide C=O stretch vibrations appear as a close doublet at 1640 and 1655 cm-l. The latter peak is similar in frequency to the 1657 cm--l shoulder observed in uncomplexed valinomycin powder, and the 1654 cm-' band observed in Ccl, and CHCl, solutions (Table l) , but the 1640 cm-l frequency is 9 cm-l lower than the lowest amide C=O stretch vibration of uncomplexed valinomycin. ) where: the scanning speed is 6 cm-'/min (1200 to 1500 cm-l 8nd 2700 to 2960 cm-l), 12 cm-l/min (2860 to 3000 cm-l), 30 cm-l (3260 to 3480 om-I); the spectral resolution is 6 cm-', exoept 2 cm-l (2700 to 2860 cm-l); the i&dent power is 90 mW, except 60 mW (3260 to 3480 cm-l), and the vertical line represents 300 cts/min, except 100 cts/s (2700 to 2860 cm-I). S denotes solvent peaks.
The ester C=O stretch vibration of powdered valinomycin-KSCN appears as a prominent single peak at 1771 cm-l, which is slightly above the free ester C=O frequency of uncomplexed valinomycin (1767 cm-l). There is a small peak near 1750 cm-l which may represent a minority conformation (a similar small peak appears as a shoulder at 1747 cm-l in uncomplexed valinomycin).
(b) Non-polar solvents Both valinomycin and its KEEN complex dissolve readily in Ccl,. The amide and ester C= 0 vibrations of uncomplexed valinomycin in CCI, solution appear as rtsymmetric broad (~25 cm-l) bands in solution ( Fig. 2(c) ). This indicates that these C=O groups now exist in a variety of different local environments with varying degrees of exposure to (and interactions with) the solvent (Rothschild et al., Ivanov et al. (1969) and Shemyakin et al. (1969) . d From Grell t Funck (1973) . e Grown from methanol (or ethanol) solution. I Valinomycin-KSCN powder (e) at the bottom of a capillary tube filled with n-octane (valinomycin is not readily dissolved in octane at room temperature).
8 Powder (e) -powder (a). h Powder (f) -powder (a). Raman spectra of Ccl, solutions of the valinomycin-KSCN complex ( Fig. 2(d) ) show a dramatic narrowing of the ester C=O peak which has about the same width (~10 cm-l) and frequency (1769 cm-l) as in the solid state. This narrowing, an expected result of complex formation, is not observable in solid-state samples (Fig.  2(b) ) since the C=O peaks of uncomplexed valinomycin powder are already quite narrow, i.e. the sample is already "locked" into a single, well-characterized conformation. The frequencies of the amide C=O bands (1645 cm-", 1660 cm-') fall between those observed in the crystalline complex (1640 cm-l, 1655 cm-l) and those observed in Ccl, solutions of uncomplexed valinomycin (1654 cm-l, 1665 cm -*).
(c) Polar solvents
Complex formation-induced narrowing of the ester C=O band of valinomycin is also observed in the polar solvents CHCl, and C,H,OH (Fig. 2(f) ). In CHCl, (Table 1 ) the ester C=O stretch frequency of the complex (1755 cm-l) is ~5 cm-' below that of uncomplexed valinomycin in the same solvent (1760 cm-l). Although the Raman spectra of uncomplexed valinomycin in Ccl, and CHCl, solutions appear almost identical in this region, the eater C=O stretch frequency of the complex is ~14 cm-l lower in CHCI,.
The ester C=O frequencies of both complexed and uncomplexed valinomycin in ethanol are near 1757 cm-l, and both are below the corresponding peaks in ClC, solutions of valinomycin resulted in spectra similar to those shown in Figure 2 (f) solvent-independent.
Several additional procedures were carried out to verify the existence of the valinomycin-K+ complex in C,H,OH. Samples obtained by two different methods (see Materials and Methods) were found to yield identical Raman spectra. Optical rotatory dispersion measurements confirmed the presence of a single maximum near 220 nm, characteristic of the complex conformation (Shemyakin et al., 1969) , and the absence of the "polar" (200 run) and "non-polar" (240 nm) conformations observed in C,H,OH solutions of uncomplexed valinomycin. The addition of KC1 to C,H,OH solutions of valinomycin resulted in spectra similar to those shown in Figure 2 (f) (valinomycin-KSCN complex) , whereas the addition of NaCl produced no changes from those in Figure 2 Table 2 ) reveal several differences in addition to those occurring in the 1600 to 1800 cm-l region. Several peaks (488, 864, 939, 1152 cm-') are greatly increased in relative intensity on complex formation. Some peaks appear only in the complex (651, 794, 923 cm-l); others (1325, 2984 cm-l) occur only in the uncomplexed form. The 1178 cm-l single peak of uncomplexed valinomycin (COC stretch) splits into a 1170, 1186 cm-l doublet in the complex; and the 1252 cm-l amide III vibrations shift to 1247 cm-l. Other complex formation. induced frequency shifts involve the 407, 839, 885 and 1003 cm-l vibrations.
It is significant that major changes occur in the 1300 to 1350 cm-l and 2900 to 2950 cm-l spectral regions upon complex formation. The peaks of these regions represent, primarily, bending and stretching modes involving the hydrocarbon side groups of valinomycin. There are further changes in the frequency and relative K. J. ROTHSCHILD AND H. E. STANLEY intensity of these modes on dissolving the valinomycin-KSCN complex in Ccl, or CHCl,. Frequencies in the 1000 to 1050 cm-l region (valyl symmetric stretch) also shift on complex formation; although the 1127 cm-l vibration (valyl antisymmetric stretch) does not.
In the solid state, the amide III vibration near 1250 cm-l increases somewhat in relative intensity upon complexation. There may be additional amide III contributions to the CH band near 1313 cm-'.
Discussion
Since the biological significance of valinomycin hinges upon its ability to shield cations (K+, Rb+, Cs+) f rom the non-polar interior of lipid membranes, an investigation of the valinomycin-K+ complex in non-polar solvents is particularly important. The Raman spectra of valinomycin-KSCN in the solid state and in CCI, solution (Figs 2 to 4) are found to be similar except for changes in the amide C=O stretch (1600 to 1700 cm-l) and valyl stretch (2850 to 3000 cm-l) regions. The former may reflect the breaking of weak 'intermolecular hydrogen bonds (or the weakening of ionic bonds to the counterion) in solution. The latter may reflect the steric effects of the close packing of the complex (and its counterion) in the solid state. Thus the X-ray structure of the crystalline complex (Pinkerton et al., 1969) would appear to be relevant to non-polar solutions as well. In contrast, Raman spectra of the complex in polar solvents display appreciable frequency shifts in the ester CL0 stretch region (1740 to 1780 cm-l) which apparently reflect solvent interactions in the vicinity of the cation co-ordinated by these groups.
In the following sections we discuss our results in the amide (section (a)) and ester (section (b)) CL0 stretch regions and in the remainder of the Raman spectrum (section (c)). The significance of the observed solvent-dependence of the ester C=O stretch frequency is elaborated upon in section (d). We also compare our results with those obtained by other methods.
(a) The amide C=O region (1600 to 1700 cm-') The amide C=O stretch region of the valinomycin-KSCN complex displays close doublets (Fig. 2(b) , (d) and (f)) with frequencies below those of uncomplexed valinomycin (1649, 1675 cm-'). The absence of the 1675 cm-l peak indicates that now all amide C=O groups are H-bonded. The down-shift in the lower peak may represent an increase in the strength of the intramolecular H-bonding of some amide CL0 groups beyond that of the "strong" H-bonds of uncomplexed valinomycin. The smallangle X-ray diffraction measurements of Krigbaum et al. (1972) show that the radius of gyration of valinomycin molecules in C,H,OH solutions drops from ~5.0 A to -3.9 A on adding KSCN. However, X-ray diffraction measurements of the N. . . 0 distances of complexed and uncomplexed valinomycin crystals vary only between -2.8 and 3-O A in both cases (Pinkerton et al., 1969; Duax personal communication) . Cur attribution of the complex formation-induced downshift in the former amide CEO stretch frequencies to increased hydrogen bonding is supported by proton nuclear magnetic resonance studies of the NH groups of valinomycin. The valine temperature coefllcient shifts from ~75 x 10e4 p.p.m./deg. C in dioxanelwater solution (in which valinomycin lacks strong hydrogen bonds) to -30 x 10m4 p.p,m./ deg. C in dioxane/octane solution (in which all NH groups are strongly hydrogen bonded; Pate1 & Tonelli 1973) . Significantly, these coefficients are still lower -19 x 10m4 p.p.m./deg. C in the valinomycin-KSCN complex in CH,OH (Ohnishi & Urry 1970) .
The appearance of a close, but well resolved, amide C=O doublet in the Raman spectrum of the complex (Fig. 2) , suggests that hydrogen bonds to these groups may be of two discrete, slightly different strengths. This conclusion is supported by recent 13C nuclear magnetic resonance spectra of valinomycin in CD,OD (Patel, 1973) , which show two amide C=O resonances with chemical shifts of 20.64 and 21.76 p.p.m. On complex formation with KSCN these shift, respectively, 1.3 and 0.9 p.p.m. further downfield. (The other two resonances of this region shift 3.6 and 5.1 p.p.m. downfield on complex formation, and were therefore assigned to ester C=O groups.) The observed shifts led Bystrov et al. (1972) to suggest that the amide C=O groups may also be interacting directly (albeit weakly) with the K+ ion.
We find the amide C=O frequencies of the valinomycin-KSCN complex to be virtually independent of solvent polarity ( Fig. 2(d) and (f) ; Table 1 ). This may be attributed to the strong hydrogen-bonding of these groups, and their shielding by the hydrocarbon side-groups of valinomycin. The appearance of this region in Raman spectra of uncomplexed vahnomycin (Fig. 2(c) and (e)) is solvent-dependent due to shifts in the equilibrium concentrations of several, simultaneously-present conformers (Ivanov et al., 1969; Pate1 & Tonelli, 1973) . The amide C=O frequencies of the valinomycin-KSCN complex are ~5 cm-1 lower in the solid state ( Fig. 2(b) ) than in solution. This may reflect additional bonding of these groups to adjacent valinomycin molecules or SCN-anions in the crystal lattice.
(b) The ester C=O region (1700 to 1800 cm-l) Raman spectra of the valinomycin-KSCN complex in both the solid state and in non-polar (Ccl,) solution display a single, narrow, intense ester C=O peak near 1770 cm-l. This suggests: (i) that all six ester C=O groups are similarly bonded; (ii) that these groups are "locked" into position and shielded from the non-polar solvent (which explains the dramatic narrowing of this peak, compared to that of uncomplexed valinomycin, in Ccl,) ; (iii) that the structure of this (presumably inner) portion of the complex is the same in both the solid state and in non-polar solution. These observations are consistent with the X-ray crystallographic structure of the valinomycin-KAuCl, complex ( Fig. l(c) ) determined by Pinkerton et al. (1969) in which all six ester C=O groups co-ordinate the enclosed cation. No parallel studies (nuclear magnetic resonance, infrared absorption) of valinomycin complexes in the solid state, or in simple (non-hydrogen-bonding) non-polar solutions, are available.
It is not surprising that this frequency (1771 cm-l in solid state, 1769 cm-l in Ccl,) is higher than both the "free" (1767 cm-l) and hydrogen-bonded (1742 cm-l) ester C=O stretch frequencies of crystalline uncomplexed valinomycin (or the 1760 cm-l frequency in Ccl, solution). The co-ordination of the K+ ion modifies the electron density distribution in the vicinity of the C= 0 bond, shifting it further toward the oxygen atom; this changes the effective carbon-oxygen force constant (the second spatial derivative of the local potential energy along the bond). Thus the relative effects of hydrogen-bonding and K+ co-ordination on the C=O stretch frequency cannot be predicted a priori, except by combining a normal mode analysis (opposing C=O groups are coupled via the cation) with a local solution of the Schriidinger equation. Such effects are usually investigated empirically, e.g. by comparing a series of model compounds. For example, it was found that hydrogen bonding consistently lowered the frequency of the amide C=O stretch vibration (Richards & Thompson, 1947; Koenig, 1972) . This is an additional reason for attributing the narrowing of ester C=O peaks unaccompanied by a frequency shift (Fig. 2(e) and (f) ) to some process other than hydrogen bonding.
Narrowing of the ester C= 0 stretch band in the moderately polar solvents, CHCl, and C,H,OH (Fig. 2(f) ), verifies the existence of valinomycin-KSCN complex formation in these solvents as well; however, the ester C=O frequency of the complex (1755 cm-l in CHCI,, 1758 cm-l in C,H,OH) is -12 cm-l lower than its value in Ccl, solution (Fig. 2(d) ). In contrast, the corresponding spectra of uncomplexed valinomycin in Ccl, and CHCl, solutions are similar (Table 1) ; both display broad bands with peaks near 1760 cm-l. This sensitivity of the ester C=O frequency to the solvent is striking since:
(i) the X-ray crystallographic structure of the complex (Fig. I(c) ) has all six ester C=O groups substantially shielded by surrounding parts of the molecule (Pinkerton et al., 1969) ;
(ii) in any case, the ester C=O groups should be less available in the complex (in which they co-ordinate the K+ ion) than in the rather open structures of uncomplexed valinomycin solution (in which the ester C=O groups are "free"; Shemyakin et al. (1969); Pate1 & Tonelli (1973) ); (iii) the amide C=O frequencies of the complex are virtually identical in Ccl,, CHCl, and C,H,OH (Fig. 2(d) and (f) ; Table 1 ).
It is interesting to compare these Raman results with infrared absorption measurements of the valinomycin-KC,,H,,OSO, complex in CHCl, (Shemyakin et al., 1969 ) and the valinomycinKC1 complex in CH,OH (Grell & Funck, 1973) . The infrared and Reman C=O frequencies differ numerically in all cases (Table 1) ; this is not surprising since Raman-active vibrations are often infrared-inactive (or vice versa) depending on the symmetry and selection rules which characterize the vibration. Complex formation in CHCla shifts the infrared stretch frequencies of both the amide and ester C=O groups downward (4 cm-l, 16 cm -I, respectively) ; the corresponding Raman displacements are also downward but different in magnitude (9 cm-l, 5 cm-l, respectively). Complex formation in CH,OH (or C,H,OH) shifts both the infrared and Raman amide C=O frequencies markedly downward (~17 cm-l) ; but the corresponding ester C=O frequencies are shifted 7 cm -I downward in the infrared, and 2 cm-l upward in the Raman.
Despite differences in the Raman and infrared frequencies (arising from differences in modes observed and perhaps the choice of counterions as well), these infrared measurements support our conclusions that :
(i) the amide C=O frequencies of the complex are about the same in CHCl, and C,H,OH (or CH,OH);
(ii) the ester C=O frequency of the complex is significantly lower in CRC& than in C,H,OH (or CH,OH); (iii) the downward shift of the amide CL0 frequency on complex formation is largest in C,H,OH $&OH), while that of the ester C=O frequency is largest in CHCl,.
Parallel infrared studies of valinomycin complexes in non-polar solvents like CC& might be helpful in verifying some of our other conclusions.
Although valinomycin and its KSCN complex are not readily soluble in octane at room temperature, Raman spectra of valinomycin-KSCN powder at the bottom of a capillary tube filled with n-octane yield a still higher ester C=O stretch frequency (1775 cm-l) that is ~6 cm-l above its value in Ccl,, and ~20 cm-l above its value in CHCl, (Table 1) . Again the amide C=O stretch frequencies are basically unchanged.
(c) Raman spectrum outside the 1600 to 1800 cm-l region Observations in other regions of the Raman spectrum of valinomycin (Table 2 , Figs 3 and 4) support the existence of widespread conformational changes in the vahnomycin backbone on complex formation (Fig. l(b) and (0)). In particular, the splitting of the 1178 cm-l peak into a sharp doublet (1170, 1186 cm-l) reflects changes in the COC stretch mode induced by the reorientation of the neighboring ester CL0 groups in the complex. The latter groups also adjoin the valyl residues of the L and n-valine subunits, which may account for the major changes which occur in the 1300 to 1350 cm-r and 2966 to 2950 cm-r regions on complex formation. These observations are supported by studies using other techniques. Ivanov et al. (1971) report shifts in the 1184 cm-l COC infrared absorption frequency of uncomplexed valinomycinin CCl,/CH&N (2 : 1 / ) vv souionfrom1194t01197cm-10nthe 1 t addition of K+ , Rb + , Cs+ or even Na +. Widespread changes in the valinomycin backbone on KSCN complex formation are observed in proton nuclear magnetic resonance spectra in CDCl, (Haynes et al., 1969) and CD,OD and CH,CN (Ivanov et al., 1969) . 13C nuclear magnetic resonance studies of valinomycin-KSCN complex formation in CDCI,/CD,OD (1:l v/v) (Bystrov et al., 1972) and CH,OH (Patel, 1973) indicate ~3 p.p.m. shifts for the C& carbons of the valine subunits, but ~1 p.p.m. shifts for the Cca) carbons of lactic and hydroxyisovaleric acid (which are further from the K+ -binding ester C=O groups). Similarly ~1.3 p.p.m. shifts are observed for the Ct~, carbons of valine but not for hydroxyisovaleric acid.
Finally, Ivanov et al. (1973) find far infrared evidence for a direct K+ . . . 0 stretching mode at 171 cm-l in the valinomycin-K+ complex. Although we observe a mode of similar frequency (169 cm-r) in Raman spectra of the complex (Fig. 3) , this may represent a frequency shift in the 158 cm-l mode of uncomplexed valinomycin rather than the appearance of a new stretching mode. The sensitivity of the ester C=O stretch frequency of the valinomycin-K+ complex to the polarity of the solvent is of great biological interest. It indicates that the enclosed ion and its surrounding ester C=O groups still interact with nearby solvent molecules, suggesting that this interaction may be involved in the release mechanism for K + ions carried to the water interface on the far side of a lipid bilayer ; it indicates further that the X-ray structure described by Pinkerton et al. (1969) may not reflect in detail the inner structure of the complex in polar solution.
The valinomycin c-* valinomycin-KSCN exchange rate, as measured in proton nuclear magnetic resonance experiments, is also solvent dependent, e.g. it is <O-2 s-l in pure CDCl,, but ~2.0 s-l in CH,OH/CDCl, (4 : 1) (Haynes et al., 1969) ; a K+ turnover rate of ~200 s-l has been reported in mitochondrial preparations (Pressman et al., 1967) .
The role of the counterion in complex formation must also be considered. Pinkerton et al. (1969) found complex formation with K+ to be anion-dependent, with picrateand AuCl; giving the best results; their X-ray crystallographic measurements show that the AuCl; anion rests in a nearly spherical cavity formed by adjacent valinomycin-K + complex molecules. They conclude that valinomycin selectively transports K + /picrate-pairs across a CHCl, barrier from the fact that adding KC1 to one side of the barrier effectively increases the migration of both K+ and picrate-(but not Cl-) ions. The ability of valinomycin to solubilize K+ in decane is also anion-dependent (Tosteson, 1972) . Picrate analogs are superior to even such lipid-soluble anions as hexanoate; the trinitrocresolate anion was found to be the most potent (although it dramatically reduces the selectivity of valinomycin as well). The SCN-anion has been found to be closely associated with the co-ordinated Rb + ion in X-ray crystallographic studies of the RbSCN-dibenzo-13crown-6 polyether complex (Bright & Truter, 1970) . The SCN-ion is inserted from above the ring in this ion-pair complex. A similar role is played by the highly polar solvent CH,CN in the Li+ antamanide complex (Karle et al., 1973; Karle, 1974a,b) .
These results suggest that the negatively charged AuCl; ion may remain associated with the positively charged valinomycin-K + complex even in CHCI, solution. If the same is true-perhaps in a lesser degree-of the valinomycin-KSCN complex : (i) the observed shift of the ester C=O peak in polar solvents may reflect the increased dissociation of the anion in polar solvents; (ii) the ester C=O groups might be particularly affected since they co-ordinate the positively charged cation, which could interact strongly with a nearby negative ion; (iii) the amide C=O groups (which circle the ring equatorially) would be relatively unaffected by changes in the anion proximity, especially since the density of peripheral hydrocarbon groups is particularly high in that region. It should be noted, however, that recent 13C-nuclear magnetic resonance studies suggest that valinomycin forms no stable association with ClO; counterions in CD,OD solution (Fedarko, 1973) .
Finally, none of our data directly contradicts the (unlikely) possibility that a totally different form of complex exists in CHCI, and C&H,OH solution in which the amide C=O groups are solvent-protected and the ester C=O groups are solventexposed. Similarly, the assignment of the most KSCN-sensitive 13C nuclear magnetic resonance carbonyl resonances of valinomycin in CD,OD to ester C=O groups was based on the apriori assumption that those groups co-ordinate the cation (Patel, 1973) .
The situation in other hydrogen-bonding solvents is even more complex. Pate1 & Tonelli (1973) observe a new, weakly H-bonded, complex conformation in dimethylformamide; recently an unusual mixture of valinomycin conformations has been observed in Raman spectra of dioxane solutions in contact with a KCl-saturated deuterium oxide phase (Rothschild et al., manuscript in preparation) . These results indicate that a true understanding of the complex formation and transport mechanisms of valinomycin still requires considerable further research using all available techniques. In particular, polarization studies and investigations of anion effects are under way.
conclusion
We have obtained the flrat complete Raman spectra of the valinomycin-K+ complex in the solid state, and in non-polar (Ccl,) and polar (CHCl,, C2H50H) solvents. Major spectral changes, such as the narrowing and frequency shifting of the amide and ester C=O stretch peaks, differentiate complexed from uncomplexed valinomycin.
The ester C=O stretch frequency is extremely solvent-sensitive; it is highest in non-polar solvents. In contrast the amide C=O stretch frequencies, while lower than in uncomplexed valinomycin, are solvent-independent.
These results suggest that the complex consists of a tight, rigid carbon framework within which the ester C=O groups and K+ ion are only partially shielded from external solvent. Gaps in the outer covering of hydrocarbon side-chains could allow a closer approach of counterions or polar solvent molecules to the center of the complex than previously suspected. This hypothesis might be investigated further using valinomycin analogs in which the hydroxyisovaleric acid subunits are replaced with lactic acid or vice versa (such analogs have already been synthesized (Shemyakin et al., 1969) ). Solvent interactions with the complexed cation may be a biologically significant part of the ion-release mechanism of such ion-carrying molecules.
